Scientific Programs Committee

Philip Sager, MD (Chair)
Pharmaceutical/Device Consultant
Biotechnology Executive
Consulting Professor
CV Safety Expert

Corina Dota, MD
AZ ECG Centre Director, CPD
Co-Chair Cardiac QT/Arrhythmia Safety Knowledge Group

Mary Jane Geiger, MD, PhD
Senior Director
Cardiovascular & Metabolism Therapeutics
Regeneron Pharmaceuticals, Inc.

Jonathan Seltzer, MD, MBA, MA
President, ACI Clinical
Director, Clinical Research, Lankenau Heart Institute

Scott D. Berkowitz, MD
Vice President and Head, Thrombosis Group Cardiovascular and Coagulation Therapeutic Area
Global Clinical Development
Bayer HealthCare Pharmaceuticals, Inc.

Catherine Ortemann-Renon, PharmD, PhD
Director, Clinical and Exploratory Pharmacology
Sanofi

Robert B. Kleiman, M.D.
Chief Medical Officer and Vice President, Global Cardiology
ERT

Valarie Morrow, MD
Project Manager
Duke Clinical Research Institute